These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
726 related items for PubMed ID: 26061549
1. Mammalian target of rapamycin signaling inhibition ameliorates vascular calcification via Klotho upregulation. Zhao Y, Zhao MM, Cai Y, Zheng MF, Sun WL, Zhang SY, Kong W, Gu J, Wang X, Xu MJ. Kidney Int; 2015 Oct; 88(4):711-21. PubMed ID: 26061549 [Abstract] [Full Text] [Related]
2. Klotho upregulation by rapamycin protects against vascular disease in CKD. Hamano T. Kidney Int; 2015 Oct; 88(4):660-2. PubMed ID: 26422620 [Abstract] [Full Text] [Related]
3. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure. Lin CY, Hsu SC, Lee HS, Lin SH, Tsai CS, Huang SM, Shih CC, Hsu YJ. J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586 [Abstract] [Full Text] [Related]
4. Microsomal Prostaglandin E Synthase-1-Derived PGE2 Inhibits Vascular Smooth Muscle Cell Calcification. Gao C, Fu Y, Li Y, Zhang X, Zhang L, Yu F, Xu SS, Xu Q, Zhu Y, Guan Y, Wang X, Kong W. Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):108-21. PubMed ID: 26543101 [Abstract] [Full Text] [Related]
8. Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of Klotho deficiency. Jimbo R, Kawakami-Mori F, Mu S, Hirohama D, Majtan B, Shimizu Y, Yatomi Y, Fukumoto S, Fujita T, Shimosawa T. Kidney Int; 2014 May; 85(5):1103-11. PubMed ID: 24088960 [Abstract] [Full Text] [Related]
9. mTOR (Mechanistic Target of Rapamycin) Inhibition Decreases Mechanosignaling, Collagen Accumulation, and Stiffening of the Thoracic Aorta in Elastin-Deficient Mice. Jiao Y, Li G, Li Q, Ali R, Qin L, Li W, Qyang Y, Greif DM, Geirsson A, Humphrey JD, Tellides G. Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1657-1666. PubMed ID: 28751568 [Abstract] [Full Text] [Related]
10. Upregulation of a disintegrin and metalloproteinase with thrombospondin motifs-7 by miR-29 repression mediates vascular smooth muscle calcification. Du Y, Gao C, Liu Z, Wang L, Liu B, He F, Zhang T, Wang Y, Wang X, Xu M, Luo GZ, Zhu Y, Xu Q, Wang X, Kong W. Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2580-8. PubMed ID: 22995515 [Abstract] [Full Text] [Related]
11. Estrogen-Related Receptor γ Plays a Key Role in Vascular Calcification Through the Upregulation of BMP2 Expression. Kim JH, Choi YK, Do JY, Choi YK, Ha CM, Lee SJ, Jeon JH, Lee WK, Choi HS, Park KG, Lee IK. Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2384-90. PubMed ID: 26404484 [Abstract] [Full Text] [Related]
12. Augmentation of phosphate-induced osteo-/chondrogenic transformation of vascular smooth muscle cells by homoarginine. Alesutan I, Feger M, Tuffaha R, Castor T, Musculus K, Buehling SS, Heine CL, Kuro-O M, Pieske B, Schmidt K, Tomaschitz A, Maerz W, Pilz S, Meinitzer A, Voelkl J, Lang F. Cardiovasc Res; 2016 Jun 01; 110(3):408-18. PubMed ID: 27001421 [Abstract] [Full Text] [Related]
13. Activation of mTOR modulates SREBP-2 to induce foam cell formation through increased retinoblastoma protein phosphorylation. Ma KL, Liu J, Wang CX, Ni J, Zhang Y, Wu Y, Lv LL, Ruan XZ, Liu BC. Cardiovasc Res; 2013 Dec 01; 100(3):450-60. PubMed ID: 24068000 [Abstract] [Full Text] [Related]
14. The mammalian target of rapamycin signalling pathway is involved in osteoblastic differentiation of vascular smooth muscle cells. Zhan JK, Wang YJ, Wang Y, Wang S, Tan P, Huang W, Liu YS. Can J Cardiol; 2014 May 01; 30(5):568-75. PubMed ID: 24518659 [Abstract] [Full Text] [Related]
15. Msx2 is required for vascular smooth muscle cells osteoblastic differentiation but not calcification in insulin-resistant ob/ob mice. Andrade MC, Carmo LS, Farias-Silva E, Liberman M. Atherosclerosis; 2017 Oct 01; 265():14-21. PubMed ID: 28829997 [Abstract] [Full Text] [Related]
16. Oligogalacturonic Acid Inhibits Vascular Calcification by Two Mechanisms: Inhibition of Vascular Smooth Muscle Cell Osteogenic Conversion and Interaction With Collagen. Hodroge A, Trécherel E, Cornu M, Darwiche W, Mansour A, Ait-Mohand K, Verissimo T, Gomila C, Schembri C, Da Nascimento S, Elboutachfaiti R, Boullier A, Lorne E, Courtois J, Petit E, Toumieux S, Kovensky J, Sonnet P, Massy ZA, Kamel S, Rossi C, Ausseil J. Arterioscler Thromb Vasc Biol; 2017 Jul 01; 37(7):1391-1401. PubMed ID: 28522698 [Abstract] [Full Text] [Related]
17. Dihydromyricetin ameliorates vascular calcification in chronic kidney disease by targeting AKT signaling. Feng L, Que D, Li Z, Zhong X, Yan J, Wei J, Zhang X, Yang P, Ou C, Chen M. Clin Sci (Lond); 2021 Nov 12; 135(21):2483-2502. PubMed ID: 34643227 [Abstract] [Full Text] [Related]
18. Inhibition of FOXO1/3 promotes vascular calcification. Deng L, Huang L, Sun Y, Heath JM, Wu H, Chen Y. Arterioscler Thromb Vasc Biol; 2015 Jan 12; 35(1):175-83. PubMed ID: 25378413 [Abstract] [Full Text] [Related]
19. Klotho/FGF23 axis mediates high phosphate-induced vascular calcification in vascular smooth muscle cells via Wnt7b/β-catenin pathway. Chen YX, Huang C, Duan ZB, Xu CY, Chen Y. Kaohsiung J Med Sci; 2019 Jul 12; 35(7):393-400. PubMed ID: 31001900 [Abstract] [Full Text] [Related]
20. Targeting vascular smooth muscle cell dysfunction with xanthine derivative KMUP-3 inhibits abdominal aortic aneurysm in mice. Lai CH, Chang CW, Lee FT, Kuo CH, Hsu JH, Liu CP, Wu HL, Yeh JL. Atherosclerosis; 2020 Mar 12; 297():16-24. PubMed ID: 32059119 [Abstract] [Full Text] [Related] Page: [Next] [New Search]